Chronic kidney disease is one of the most rapidly increasing chronic diseases in the United States. More than 20 million US adults have an estimated glomerular filtration rate of less than 60 mL/min/1.73m2, which represents loss of more than half of normal kidney function.1 Disturbances in phosphorus, calcium, and vitamin D metabolic pathways develop early during chronic kidney disease and eventually affect most patients during the course of their disease.2 Data from cell culture and animal models suggest that mineral metabolism disorders might play a causal role in the development of vascular calcification, arterial stiffness, and ventricular hypertrophy.3- 5 Biomarker studies of serum concentrations of phosphorus, calcium, and parathyroid hormone provide complementary data for evaluating whether these metabolic pathways might contribute to the development of clinical disease outcomes in humans.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.